Cargando…
Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease
Background: Instances of resistant fungal infection are rising in pulmonary disease, with limited therapeutic options. Therapeutic drug monitoring of azole antifungals has been necessary to ensure safety and efficacy but is considered unnecessary for the newest triazole isavuconazole. Aims: To chara...
Autores principales: | Nwankwo, Lisa, Gilmartin, Desmond, Matharu, Sheila, Nuh, Ali, Donovan, Jackie, Armstrong-James, Darius, Shah, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029347/ https://www.ncbi.nlm.nih.gov/pubmed/35448593 http://dx.doi.org/10.3390/jof8040362 |
Ejemplares similares
-
COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment—A Retrospective Study
por: Nuh, Ali, et al.
Publicado: (2023) -
Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016) -
P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022) -
Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
por: Nuh, Ali, et al.
Publicado: (2022) -
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study
por: Nwankwo, Lisa, et al.
Publicado: (2022)